United States· US:59390-149_0561ff06-43b4-493e-93f7-b778fc829036
Diclofenac
A diclofenac product containing diclofenac sodium, registered in United States by Altaire Pharmaceuticals Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Diclofenac is registered in 13 of 19 countries.
Countries holding a registration under ATC S01BC03 (diclofenac), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Diclofenac · ATC S01BC03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DICLOFENAC SODIUM
- Manufacturer
- Altaire Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- S01BC03
- ATC class
- Diclofenac
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1159390-149-02
- ndc1159390-149-05
- ndc1159390149021 BOTTLE, DROPPER in 1 CARTON (59390-149-02) / 2.5 mL in 1 BOTTLE, DROPPER
- ndc1159390149051 BOTTLE, DROPPER in 1 CARTON (59390-149-05) / 5 mL in 1 BOTTLE, DROPPER
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
90 interactions on record for diclofenac.
Graded by severity as the source publishes them — 89 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diclofenac · interactions on record
90 records
- 89 moderate
- 1 minor
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diclofenac in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayDiclo-Vision sineOmniVision
- SwedenDicloabak 1 mg/ml Ögondroppar, lösning2care4 ApS
- NetherlandsDicloabak 1 mg/ml, oogdruppels, oplossingLaboratoires Théa
- FinlandDicloabakLaboratoires Thea
- PolandDicloabakLaboratoires Thea
- CzechiaDICLOABAKLaboratoires Thea, Clermont-Ferrand
- FranceVOLTARENOPHTA 0,1 POUR CENT (0,3 mg/0,3 ml), collyre en solution en récipient unidoseTHEA
- BelgiumDicloabak 1 mg/ml 0.1 %Laboratoires Théa
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dedolor Akut, Dedolor Drs
- Belgium · Cataflam, Dicloabak
- Bulgaria · Diclofenac-Tchaikapharma, Алмирал
- Cyprus · Almiral, Areston
- Czechia · Almiral, Dicloabak
- Germany · Arthrex Schmerzgel, Diclac
- Denmark · Diclodan, Diclofenac Bluefish
- Estonia · Almiral, Dagesil
- Spain · Cinfadol, Dagesil
- Finland · Dicloabak, Diclomex Rapid
- France · Antalcalm, Diclamine
- United Kingdom (Northern Ireland) · Akis, Amgesic Muscle & Back Pain Relief
- Greece · Batafil, Denaclof
- Croatia · Diclac Duo, Diclo Duo
- Hungary · Algoplast, Cataflam
- Ireland · Cataflam, Diclac
- Iceland · Diclofenac Alvogen, Dimax
- Italy · Brexiadvance, Dealgic
- Lithuania · Dagesil, Diclac
- Luxembourg · Cataflam, Dicloabak
- Latvia · Almiral, Dagesil
- Malta · Almiral, Areston
- Netherlands · Areston, Dicloabak
- Norway · Cataflam, Diclofenac Bluefish
- Poland · Adarostin, Akis
- Portugal · Dagesil, Dicipan
- Romania · Almiral, Clafen
- Sweden · Dicloabak, Diclofenac Bluefish
- Slovenia · Diclo Duo, Dicloflex
- Slovakia · Akis Plus, Almiral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48ad25d2-3ebf-4b2c-b259-cc12eba5ebf0 GET /v1/drugs/48ad25d2-3ebf-4b2c-b259-cc12eba5ebf0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "1",
"substance": "DICLOFENAC SODIUM",
"productndc": "59390-149",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA203383",
"marketing_category": "ANDA"
}See everything about diclofenac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.